Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Max, N; Keilholz, U
   Minimal residual disease in melanoma
   SEMINARS IN SURGICAL ONCOLOGY
   
   N. Max e U. Keilholz, "Minimal residual disease in melanoma", SEM SURG ON, 20(4), 2001, pp. 319-328
2. Riley, JP; Rosenberg, SA; Parkhurst, MR
   Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase
   JOURNAL OF IMMUNOTHERAPY
   
   J.P. Riley et al., "Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase", J IMMUNOTH, 24(3), 2001, pp. 212-220
3. Lau, R; Wang, F; Jeffery, G; Marty, V; Kuniyoshi, J; Bade, E; Ryback, ME; Weber, J
   Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma
   JOURNAL OF IMMUNOTHERAPY
   
   R. Lau et al., "Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma", J IMMUNOTH, 24(1), 2001, pp. 66-78
4. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
   Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   S. Nawrocki et al., "Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer", EXPERT OP B, 1(2), 2001, pp. 193-204
5. Smith, ES; Mandokhot, A; Evans, EE; Mueller, L; Borrello, MA; Sahasrabudhe, DM; Zauderer, M
   Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens
   NATURE MEDICINE
   
   E.S. Smith et al., "Lethality-based selection of recombinant genes in mammalian cells: Application to identifying tumor antigens", NAT MED, 7(8), 2001, pp. 967-972
6. Wolfers, J; Lozier, A; Raposo, G; Regnault, A; Thery, C; Masurier, C; Flament, C; Pouzieux, S; Faure, F; Tursz, T; Angevin, E; Amigorena, S; Zitvogel, L
   Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming
   NATURE MEDICINE
   
   J. Wolfers et al., "Tumor-derived exosomes are a source of shared tumor rejection antigens forCTL cross-priming", NAT MED, 7(3), 2001, pp. 297-303
7. Sadanaga, N; Nagashima, H; Mashino, K; Tahara, K; Yamaguchi, H; Ohta, M; Fujie, T; Tanaka, F; Inoue, H; Takesako, K; Akiyoshi, T; Mori, M
   Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas
   CLINICAL CANCER RESEARCH
   
   N. Sadanaga et al., "Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas", CLIN CANC R, 7(8), 2001, pp. 2277-2284
8. Nishiyama, T; Tachibana, M; Horiguchi, Y; Nakamura, K; Ikeda, Y; Takesako, K; Murai, M
   Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
   CLINICAL CANCER RESEARCH
   
   T. Nishiyama et al., "Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide", CLIN CANC R, 7(1), 2001, pp. 23-31
9. Stinchcombe, JC; Bossi, G; Booth, S; Griffiths, GM
   The immunological synapse of CTL contains a secretory domain and membrane bridges
   IMMUNITY
   
   J.C. Stinchcombe et al., "The immunological synapse of CTL contains a secretory domain and membrane bridges", IMMUNITY, 15(5), 2001, pp. 751-761
10. Jungbluth, AA; King, R; Fisher, DE; Iversen, K; Coplan, K; Kolb, D; Williamson, B; Chen, YT; Stockert, E; Old, LJ; Busam, KJ
    Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    A.A. Jungbluth et al., "Immunohistochemical and reverse transcription-polymerase chain reaction expression analysis of tyrosinase and microphthalmia-associated transcriptionfactor in angiomyolipomas", APPL IMMUNO, 9(1), 2001, pp. 29-34
11. Dunussi-Joannopoulos, K; Leonard, JP
    Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia
    LEUKEMIA & LYMPHOMA
    
    K. Dunussi-Joannopoulos e J.P. Leonard, "Interleukin-12 gene therapy vaccines: Directing the immune system against minimal residual leukemia", LEUK LYMPH, 41(5-6), 2001, pp. 483
12. Weber, JS; Aparicio, A
    Novel immunologic approaches to the management of malignant melanoma
    CURRENT OPINION IN ONCOLOGY
    
    J.S. Weber e A. Aparicio, "Novel immunologic approaches to the management of malignant melanoma", CURR OPIN O, 13(2), 2001, pp. 124-128
13. Jager, D; Jager, E; Knuth, A
    Targets for immunotherapy in breast cancer
    BREAST
    
    D. Jager et al., "Targets for immunotherapy in breast cancer", BREAST, 10, 2001, pp. 23-26
14. Jager, E; Jager, D; Knuth, A
    Vaccines in breast cancer
    BREAST
    
    E. Jager et al., "Vaccines in breast cancer", BREAST, 10, 2001, pp. 158-160
15. Zendman, AJW; de Wit, NJW; van Kraats, AA; Weidle, UH; Ruiter, DJ; van Muijen, GNP
    Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma
    MELANOMA RESEARCH
    
    A.J.W. Zendman et al., "Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma", MELANOMA RE, 11(5), 2001, pp. 451-459
16. Kulik, J; Nowecki, ZI; Rutkowski, P; Ruka, W; Rochowska, M; Skurzak, H; Siedlecki, JA
    Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay
    MELANOMA RESEARCH
    
    J. Kulik et al., "Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay", MELANOMA RE, 11(1), 2001, pp. 65-73
17. Van den Eynde, BJ; Morel, S
    Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome
    CURRENT OPINION IN IMMUNOLOGY
    
    B.J. Van den Eynde e S. Morel, "Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome", CURR OP IM, 13(2), 2001, pp. 147-153
18. Soloski, MJ
    Recognition of tumor cells by the innate immune system
    CURRENT OPINION IN IMMUNOLOGY
    
    M.J. Soloski, "Recognition of tumor cells by the innate immune system", CURR OP IM, 13(2), 2001, pp. 154-162
19. Wang, TT; Fan, LQ; Watanabe, Y; McNeill, P; Fanger, GR; Persing, DH; Reed, SG
    L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma
    ONCOGENE
    
    T.T. Wang et al., "L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma", ONCOGENE, 20(53), 2001, pp. 7699-7709
20. Kavalar, R; Sarcevic, B; Spagnoli, GC; Separovic, V; Samija, M; Terracciano, L; Heberer, M; Juretic, A
    Expression of MAGE tumour-associated antigens is inversely correlated withtumour differentiation in invasive ductal breast cancers: an immunohistochemical study
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    R. Kavalar et al., "Expression of MAGE tumour-associated antigens is inversely correlated withtumour differentiation in invasive ductal breast cancers: an immunohistochemical study", VIRCHOWS AR, 439(2), 2001, pp. 127-131
21. Smyth, MJ; Kelly, JM; Sutton, VR; Davis, JE; Browne, KA; Sayers, TJ; Trapani, JA
    Unlocking the secrets of cytotoxic granule proteins
    JOURNAL OF LEUKOCYTE BIOLOGY
    
    M.J. Smyth et al., "Unlocking the secrets of cytotoxic granule proteins", J LEUK BIOL, 70(1), 2001, pp. 18-29
22. Lee, P; Wang, F; Kuniyoshi, J; Rubio, V; Stuges, T; Groshen, S; Gee, C; Lau, R; Jeffery, G; Margolin, K; Marty, V; Weber, J
    Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma
    JOURNAL OF CLINICAL ONCOLOGY
    
    P. Lee et al., "Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma", J CL ONCOL, 19(18), 2001, pp. 3836-3847
23. Raulet, DH; Vance, RE; McMahon, CW
    Regulation of the natural killer cell receptor repertoire
    ANNUAL REVIEW OF IMMUNOLOGY
    
    D.H. Raulet et al., "Regulation of the natural killer cell receptor repertoire", ANN R IMMUN, 19, 2001, pp. 291-330
24. Kawano, Y; Sasaki, M; Nakahira, K; Yoshimine, T; Shimizu, K; Wada, H; Ikenaka, K
    Structural characterization and chromosomal localization of the MAGE-E1 gene
    GENE
    
    Y. Kawano et al., "Structural characterization and chromosomal localization of the MAGE-E1 gene", GENE, 277(1-2), 2001, pp. 129-137
25. Mazzocchi, A; Melani, C; Rivoltini, L; Castelli, C; Del Vecchio, M; Lombardo, C; Colombo, MP; Parmiani, G
    Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    A. Mazzocchi et al., "Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cellsto be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes", CANCER IMMU, 50(4), 2001, pp. 199-211
26. Renkvist, N; Castelli, C; Robbins, PF; Parmiani, G
    A listing of human tumor antigens recognized by T cells
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    N. Renkvist et al., "A listing of human tumor antigens recognized by T cells", CANCER IMMU, 50(1), 2001, pp. 3-15
27. Srivastava, PK; Amato, RJ
    Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents
    VACCINE
    
    P.K. Srivastava e R.J. Amato, "Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents", VACCINE, 19(17-19), 2001, pp. 2590-2597
28. Moingeon, P
    Cancer vaccines
    VACCINE
    
    P. Moingeon, "Cancer vaccines", VACCINE, 19(11-12), 2001, pp. 1305-1326
29. Chersi, A; Garzillo, C; Butler, RH; Tanigaki, N
    Allele- and temperature-dependency of in vitro HLA class I assembly
    HUMAN IMMUNOLOGY
    
    A. Chersi et al., "Allele- and temperature-dependency of in vitro HLA class I assembly", HUMAN IMMUN, 62(8), 2001, pp. 858-868
30. Wataya, H; Kamikawaji, N; Nakanishi, Y; Takayama, K; Hara, N; Sasazuki, T
    Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line
    HUMAN IMMUNOLOGY
    
    H. Wataya et al., "Quantitation of HLA-A*0201 bound tumor associated antigens on a peptide pulsed B cell line", HUMAN IMMUN, 62(2), 2001, pp. 125-132
31. Ma, ZY; Khatlani, TS; Li, L; Sasaki, K; Okuda, M; Inokuma, H; Onishi, T
    Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    
    Z.Y. Ma et al., "Molecular cloning and expression analysis of feline melanoma antigen (MAGE) obtained from a lymphoma cell line", VET IMMUNOL, 83(3-4), 2001, pp. 241-252
32. Haverson, K; Saalmuller, A; Alvarez, B; Alonso, F; Bailey, M; Bianchi, ATJ; Boersma, WJA; Chen, Z; Davis, WC; Dominguez, J; Engelhardt, H; Ezquerra, A; Grosmaire, LS; Hamilton, MJ; Hollemweguer, E; Huang, CA; Khanna, KV; Kuebart, G; Lackovic, G; Ledbetter, JA; Lee, R; Llanes, D; Lunney, JK; McCullough, KC; Molitor, T; Nielsen, J; Niewold, TA; Pescovitz, MD; de la Lastra, JP; Rehakova, Z; Salmon, H; Schnitzlein, WM; Seebach, J; Simon, A; Sinkora, J; Sinkora, M; Stokes, CR; Summerfield, A; Sver, L; Thacker, E; Valpotic, I; Yang, H; Zuckermann, FA; Zwart, R
    Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
    
    K. Haverson et al., "Overview of the Third International Workshop on Swine Leukocyte Differentiation Antigens", VET IMMUNOL, 80(1-2), 2001, pp. 5-23
33. Ahmad, R; Sindhu, STAK; Tran, P; Toma, E; Morisset, R; Menezes, J; Ahmad, A
    Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients
    JOURNAL OF MEDICAL VIROLOGY
    
    R. Ahmad et al., "Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients", J MED VIROL, 65(3), 2001, pp. 431-440
34. Cheung, IY; Cheung, NKV
    Detection of microscopic disease: Comparing histology, immunocytology, andRT-PCR of tyrosine hydroxylase, GAGE, and MAGE
    MEDICAL AND PEDIATRIC ONCOLOGY
    
    I.Y. Cheung e N.K.V. Cheung, "Detection of microscopic disease: Comparing histology, immunocytology, andRT-PCR of tyrosine hydroxylase, GAGE, and MAGE", MED PED ONC, 36(1), 2001, pp. 210-212
35. Safa, MM; Foon, KA
    Adjuvant immunotherapy for melanoma, and colorectal cancers
    SEMINARS IN ONCOLOGY
    
    M.M. Safa e K.A. Foon, "Adjuvant immunotherapy for melanoma, and colorectal cancers", SEMIN ONCOL, 28(1), 2001, pp. 68-92
36. Gravekamp, C
    Tailoring cancer vaccines to the elderly: the importance of suitable mousemodels
    MECHANISMS OF AGEING AND DEVELOPMENT
    
    C. Gravekamp, "Tailoring cancer vaccines to the elderly: the importance of suitable mousemodels", MECH AGE D, 122(11), 2001, pp. 1087-1105
37. Robertson, H; Wong, WK; Talbot, D; Burt, AD; Kirby, JA
    Tubulitis after renal transplantation: Demonstration of an association between CD103+T cells, transforming growth factor beta(1) expression and rejection grade
    TRANSPLANTATION
    
    H. Robertson et al., "Tubulitis after renal transplantation: Demonstration of an association between CD103+T cells, transforming growth factor beta(1) expression and rejection grade", TRANSPLANT, 71(2), 2001, pp. 306-313
38. Jager, D; Jagar, E; Knuth, A
    Vaccination for malignant melanoma: Recent developments
    ONCOLOGY
    
    D. Jager et al., "Vaccination for malignant melanoma: Recent developments", ONCOL-BASEL, 60(1), 2001, pp. 1-7
39. Rosenberg, SA
    Progress in human tumour immunology and immunotherapy
    NATURE
    
    S.A. Rosenberg, "Progress in human tumour immunology and immunotherapy", NATURE, 411(6835), 2001, pp. 380-384
40. Ono, T; Kurashige, T; Harada, N; Noguchi, Y; Saika, T; Niikawa, N; Aoe, M; Nakamura, S; Higashi, T; Hiraki, A; Wada, H; Kumon, H; Old, LJ; Nakayama, E
    Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    T. Ono et al., "Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen", P NAS US, 98(6), 2001, pp. 3282-3287
41. Goydos, JS; Patel, M; Shih, WC
    NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma
    JOURNAL OF SURGICAL RESEARCH
    
    J.S. Goydos et al., "NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma", J SURG RES, 98(2), 2001, pp. 76-80
42. Mullins, DW; Bullock, TNJ; Colella, TA; Robila, VV; Engelhard, VH
    Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice
    JOURNAL OF IMMUNOLOGY
    
    D.W. Mullins et al., "Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice", J IMMUNOL, 167(9), 2001, pp. 4853-4860
43. Salio, M; Shepherd, D; Dunbar, PR; Palmowski, M; Murphy, K; Wu, LJ; Cerundolo, V
    Mature dendritic cells prime functionally superior melan-A-specific CD8(+)lymphocytes as compared with nonprofessional APC
    JOURNAL OF IMMUNOLOGY
    
    M. Salio et al., "Mature dendritic cells prime functionally superior melan-A-specific CD8(+)lymphocytes as compared with nonprofessional APC", J IMMUNOL, 167(3), 2001, pp. 1188-1197
44. Roberts, AI; Lee, L; Schwarz, E; Groh, V; Spies, T; Ebert, EC; Jabri, B
    Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment
    JOURNAL OF IMMUNOLOGY
    
    A.I. Roberts et al., "Cutting edge: NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment", J IMMUNOL, 167(10), 2001, pp. 5527-5530
45. Beck-Engeser, GB; Monach, PA; Mumberg, D; Yang, F; Wanderling, S; Schreiber, K; Espinosa, R; Le Beau, MM; Meredith, SC; Schreiber, H
    Point mutation in essential genes with loss or mutation of the second allele: Relevance to the retention of tumor-specific antigens
    JOURNAL OF EXPERIMENTAL MEDICINE
    
    G.B. Beck-Engeser et al., "Point mutation in essential genes with loss or mutation of the second allele: Relevance to the retention of tumor-specific antigens", J EXP MED, 194(3), 2001, pp. 285-299
46. Jager, D; Jager, E; Knuth, A
    Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer
    JOURNAL OF CLINICAL PATHOLOGY
    
    D. Jager et al., "Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer", J CLIN PATH, 54(9), 2001, pp. 669-674
47. Berset, M; Cerottini, JP; Guggisberg, D; Romero, P; Burri, F; Rimoldi, D; Panizzon, RG
    Expression of Melan-A/MART-1 antigen as a prognostic reactor in primary cutaneous melanoma
    INTERNATIONAL JOURNAL OF CANCER
    
    M. Berset et al., "Expression of Melan-A/MART-1 antigen as a prognostic reactor in primary cutaneous melanoma", INT J CANC, 95(1), 2001, pp. 73-77
48. Dalerba, P; Frascella, E; Macino, B; Mandruzzato, S; Zambon, A; Rosolen, A; Carli, M; Ninfo, V; Zanovello, P
    MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas
    INTERNATIONAL JOURNAL OF CANCER
    
    P. Dalerba et al., "MAGE, BAGE and GAGE gene expression in human rhabdomyosarcomas", INT J CANC, 93(1), 2001, pp. 85-90
49. Jungbluth, AA; Chen, YT; Stockert, E; Busam, KJ; Kolb, D; Iversen, K; Coplan, K; Williamson, B; Altorki, N; Old, LJ
    Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
    INTERNATIONAL JOURNAL OF CANCER
    
    A.A. Jungbluth et al., "Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues", INT J CANC, 92(6), 2001, pp. 856-860
50. Gasparollo, A; Coral, S; Ciullo, M; Prisco, A; Cattarossi, I; Sigalotti, L; Altomonte, M; Guardiola, J; Maio, M
    Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma
    INTERNATIONAL JOURNAL OF CANCER
    
    A. Gasparollo et al., "Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma", INT J CANC, 91(4), 2001, pp. 500-507
51. Smith, C; Cerundolo, V
    Immunotherapy of melanoma
    IMMUNOLOGY
    
    C. Smith e V. Cerundolo, "Immunotherapy of melanoma", IMMUNOLOGY, 104(1), 2001, pp. 1-7
52. Benlalam, H; Labarriere, N; Linard, B; Derre, L; Diez, E; Pandolfino, MC; Bonneville, M; Jotereau, F
    Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    H. Benlalam et al., "Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy", EUR J IMMUN, 31(7), 2001, pp. 2007-2015
53. Chaux, P; Lethe, B; Van Snick, J; Corthals, J; Schultz, ES; Cambiaso, CL; Boon, T; van der Bruggen, P
    A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    P. Chaux et al., "A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells", EUR J IMMUN, 31(6), 2001, pp. 1910-1916
54. Chiplunkar, SV
    The immune system and cancer
    CURRENT SCIENCE
    
    S.V. Chiplunkar, "The immune system and cancer", CURRENT SCI, 81(5), 2001, pp. 542-548
55. Jager, D; Stockert, E; Gure, AO; Scanlan, MJ; Karbach, J; Jager, E; Knuth, A; Old, LJ; Chen, YT
    Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library
    CANCER RESEARCH
    
    D. Jager et al., "Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library", CANCER RES, 61(5), 2001, pp. 2055-2061
56. Hanada, K; Perry-Lalley, DM; Ohnmacht, GA; Bettinotti, MP; Yang, JC
    Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas
    CANCER RESEARCH
    
    K. Hanada et al., "Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas", CANCER RES, 61(14), 2001, pp. 5511-5516
57. Kurashige, T; Noguchi, Y; Saika, T; Ono, T; Nagata, Y; Jungbluth, A; Ritter, G; Chen, YT; Stockert, E; Tsushima, T; Kumon, H; Old, LJ; Nakayama, E
    NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade
    CANCER RESEARCH
    
    T. Kurashige et al., "NY-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: Correlation with tumor grade", CANCER RES, 61(12), 2001, pp. 4671-4674
58. Lo Piccolo, MS; Cheung, NKV; Cheung, IY
    GD2 synthase - A new molecular marker for detecting neuroblastoma
    CANCER
    
    M.S. Lo Piccolo et al., "GD2 synthase - A new molecular marker for detecting neuroblastoma", CANCER, 92(4), 2001, pp. 924-931
59. Aubry, F; Satie, AP; Rioux-Leclercq, N; Rajpert-De Meyts, E; Spagnoli, GC; Chomez, P; De Backer, O; Jegou, B; Samson, M
    MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors
    CANCER
    
    F. Aubry et al., "MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors", CANCER, 92(11), 2001, pp. 2778-2785
60. Zambon, A; Mandruzzato, S; Parenti, A; Macino, B; Dalerba, P; Ruol, A; Merigliano, S; Zaninotto, G; Zanovello, P
    MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia
    CANCER
    
    A. Zambon et al., "MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia", CANCER, 91(10), 2001, pp. 1882-1888
61. Chouaib, S; Echchakir, H; Angevin, E; Guerra, N; Kosmatopoulos, K; Caignard, A; Lim, A; Baron, V; Ferradini, L; Mami-Chouaib, F
    Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring
    BULLETIN DU CANCER
    
    S. Chouaib et al., "Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring", B CANCER, 88(8), 2001, pp. 733-740
62. Armstrong, AC; Hawkins, RE
    Vaccines in oncology: background and clinical potential
    BRITISH JOURNAL OF RADIOLOGY
    
    A.C. Armstrong e R.E. Hawkins, "Vaccines in oncology: background and clinical potential", BR J RADIOL, 74(887), 2001, pp. 991-1002
63. Mashino, K; Sadanaga, N; Tanaka, F; Yamaguchi, H; Nagashima, H; Inoue, H; Sugimachi, K; Mori, M
    Expression of multiple cancer-testis antigen genes in gastrointestinal andbreast carcinomas
    BRITISH JOURNAL OF CANCER
    
    K. Mashino et al., "Expression of multiple cancer-testis antigen genes in gastrointestinal andbreast carcinomas", BR J CANC, 85(5), 2001, pp. 713-720
64. Harig, S; Witzens, M; Krackhardt, AM; Trojan, A; Barrett, P; Broderick, R; Zauls, AJ; Gribben, JG
    Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues
    BLOOD
    
    S. Harig et al., "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues", BLOOD, 98(10), 2001, pp. 2999-3005
65. Westbrook, VA; Diekman, AB; Naaby-Hansen, S; Coonrod, SA; Klotz, KL; Thomas, TS; Norton, EJ; Flickinger, CJ; Herr, JC
    Differential nuclear localization of the cancer/testis-associated protein,SPAN-X/CTp11, in transfected cells and in 50% of human spermatozoa
    BIOLOGY OF REPRODUCTION
    
    V.A. Westbrook et al., "Differential nuclear localization of the cancer/testis-associated protein,SPAN-X/CTp11, in transfected cells and in 50% of human spermatozoa", BIOL REPROD, 64(1), 2001, pp. 345-358
66. Mosse, CA; Hsu, W; Engelhard, VH
    Tyrosinase degradation via two pathways during reverse translocation to the cytosol
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    C.A. Mosse et al., "Tyrosinase degradation via two pathways during reverse translocation to the cytosol", BIOC BIOP R, 285(2), 2001, pp. 313-319
67. Cao, JN; Gao, TW; Stanbridge, EJ; Irie, R
    RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    J.N. Cao et al., "RBP1L1, a retinoblastoma-binding protein-related gene encoding an antigenic epitope abundantly expressed in human carcinomas and normal testis", J NAT CANC, 93(15), 2001, pp. 1159-1165
68. Jager, E; Jager, D; Knuth, A
    Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    E. Jager et al., "Perspectives of tumour immunology: antigen-specific immunotherapy of malignant diseases", DEUT MED WO, 126(37), 2001, pp. 1011-1016
69. Rosenberg, SA
    Identification of cancer antigens: Impact on development of cancer immunotherapies
    CANCER JOURNAL
    
    S.A. Rosenberg, "Identification of cancer antigens: Impact on development of cancer immunotherapies", CANCER J, 6, 2000, pp. S200-S207
70. Rosenberg, SA
    The identification of cancer antigens: Impact on the development of cancervaccines
    CANCER JOURNAL
    
    S.A. Rosenberg, "The identification of cancer antigens: Impact on the development of cancervaccines", CANCER J, 6, 2000, pp. S142-S149
71. Scheibenbogen, C; Schmittel, A; Keilholz, U; Allgauer, T; Hofmann, U; Max, R; Thiel, E; Schadendorf, D
    Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma
    JOURNAL OF IMMUNOTHERAPY
    
    C. Scheibenbogen et al., "Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma", J IMMUNOTH, 23(2), 2000, pp. 275-281
72. Pietersz, GA; Apostolopoulos, V; McKenzie, IFC
    Generation of cellular immune responses to antigenic tumor peptides
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    G.A. Pietersz et al., "Generation of cellular immune responses to antigenic tumor peptides", CELL MOL L, 57(2), 2000, pp. 290-310
73. Hicks, MJ; Flaitz, CM
    Oral mucosal melanoma: epidemiology and pathobiology
    ORAL ONCOLOGY
    
    M.J. Hicks e C.M. Flaitz, "Oral mucosal melanoma: epidemiology and pathobiology", ORAL ONCOL, 36(2), 2000, pp. 152-169
74. Jones, LA; Salgaller, ML
    Immunologic approaches to antigen discovery for cancer vaccines
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    L.A. Jones e M.L. Salgaller, "Immunologic approaches to antigen discovery for cancer vaccines", EXPERT OP I, 9(3), 2000, pp. 481-489
75. Frost, P; Bonavida, B
    Circumvention of tumor cell escape following specific immunotherapy
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    
    P. Frost e B. Bonavida, "Circumvention of tumor cell escape following specific immunotherapy", CANC BIO R, 15(2), 2000, pp. 141-152
76. Rosenberg, SA
    Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    
    S.A. Rosenberg, "Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer", CA J SCI AM, 6, 2000, pp. S2-S7
77. Sahin, U; Koslowski, M; Tureci, O; Eberle, T; Zwick, C; Romeike, B; Moringlane, JR; Schwechheimer, K; Feiden, W; Pfreundschuh, M
    Expression of cancer testis genes in human brain tumors
    CLINICAL CANCER RESEARCH
    
    U. Sahin et al., "Expression of cancer testis genes in human brain tumors", CLIN CANC R, 6(10), 2000, pp. 3916-3922
78. Morel, S; Levy, F; Burlet-Schiltz, O; Brasseur, F; Probst-Kepper, M; Peitrequin, AL; Monsarrat, B; Van Velthoven, R; Cerottini, JC; Boon, T; Gairin, JE; Van den Eynde, BJ
    Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
    IMMUNITY
    
    S. Morel et al., "Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells", IMMUNITY, 12(1), 2000, pp. 107-117
79. Asai, T; Storkus, WJ; Whiteside, TL
    Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    
    T. Asai et al., "Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines", CL DIAG LAB, 7(2), 2000, pp. 145-154
80. Robinson, C; Callow, M; Stevenson, S; Scott, B; Robinson, BWS; Lake, RA
    Serologic responses in patients with malignant mesothelioma - Evidence forboth public and private specificities
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    
    C. Robinson et al., "Serologic responses in patients with malignant mesothelioma - Evidence forboth public and private specificities", AM J RESP C, 22(5), 2000, pp. 550-556
81. Walsh, P; Gouzalez, R; Dow, S; Elmslie, R; Potter, T; Glode, LM
    A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma
    HUMAN GENE THERAPY
    
    P. Walsh et al., "A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma", HUM GENE TH, 11(9), 2000, pp. 1355-1368
82. Brenner, MK; Heslop, H; Krance, R; Horowitz, M; Strother, D; Nuchtern, J; Grilley, B; Martingano, E; Cooper, K
    Clinical protocol - Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector
    HUMAN GENE THERAPY
    
    M.K. Brenner et al., "Clinical protocol - Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector", HUM GENE TH, 11(10), 2000, pp. 1477-1488
83. Brinckerhoff, LH; Thompson, LW; Slingluff, GL
    Melanoma vaccines
    CURRENT OPINION IN ONCOLOGY
    
    L.H. Brinckerhoff et al., "Melanoma vaccines", CURR OPIN O, 12(2), 2000, pp. 163-173
84. Plate, JMD; Harris, JE
    Immune cell functions in pancreatic cancer
    CRITICAL REVIEWS IN IMMUNOLOGY
    
    J.M.D. Plate e J.E. Harris, "Immune cell functions in pancreatic cancer", CR R IMMUN, 20(5), 2000, pp. 375-392
85. Chen, Q; Jackson, H; Cebon, J; Gibbs, P; Davis, ID; Trapani, JA
    A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A(27-35) and Melan-A(26-35)
    MELANOMA RESEARCH
    
    Q. Chen et al., "A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A(27-35) and Melan-A(26-35)", MELANOMA RE, 10(1), 2000, pp. 16-25
86. Edelson, BT; Unanue, ER
    Immunity to Listeria infection
    CURRENT OPINION IN IMMUNOLOGY
    
    B.T. Edelson e E.R. Unanue, "Immunity to Listeria infection", CURR OP IM, 12(4), 2000, pp. 425-431
87. Renner, C; Trumper, L; Pfreundschuh, M
    Tumour vaccines: a new immunotherapeutic approach in oncology
    ANNALS OF HEMATOLOGY
    
    C. Renner et al., "Tumour vaccines: a new immunotherapeutic approach in oncology", ANN HEMATOL, 79(12), 2000, pp. 651-659
88. Clotman, F; De Backer, O; De Plaen, E; Boon, T; Picard, J
    Cell- and stage-specific expression of Mage genes during mouse spermatogenesis
    MAMMALIAN GENOME
    
    F. Clotman et al., "Cell- and stage-specific expression of Mage genes during mouse spermatogenesis", MAMM GENOME, 11(8), 2000, pp. 696-699
89. Niiya, F; Nishizaka, S; Matsunaga, K; Koufuji, K; Mori, M; Katai, H; Yamana, H; Itoh, K
    Expression of SART3 tumor-rejection antigen in gastric cancers
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    F. Niiya et al., "Expression of SART3 tumor-rejection antigen in gastric cancers", JPN J CANC, 91(3), 2000, pp. 337-342
90. Busam, KJ; Iversen, K; Berwick, M; Spagnoli, GC; Old, LJ; Jungbluth, AA
    Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters
    MODERN PATHOLOGY
    
    K.J. Busam et al., "Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters", MOD PATHOL, 13(4), 2000, pp. 459-465
91. Heisele, O; Ferdats, A; Engele, L
    Melanoma associated antigens as additional markers of tumor progression
    JOURNAL OF TUMOR MARKER ONCOLOGY
    
    O. Heisele et al., "Melanoma associated antigens as additional markers of tumor progression", J TUMOR M, 15(2), 2000, pp. 147-153
92. Jager, E; Jager, D; Knuth, A
    Peptide vaccination in clinical oncology
    ONKOLOGIE
    
    E. Jager et al., "Peptide vaccination in clinical oncology", ONKOLOGIE, 23(5), 2000, pp. 410-415
93. Chen, HS; Cai, SL; Wang, Y; Zhao, HT; Peng, J; Pang, XW; Zhu, JY; Cong, Y; Rui, J; Leng, XS; Du, RY; Wang, Y; Vaughan, H; Cebon, J; Burgess, AW; Chen, WF
    Expression of the MAGE-1 gene in human hepatocellular carcinomas
    CHINESE MEDICAL JOURNAL
    
    H.S. Chen et al., "Expression of the MAGE-1 gene in human hepatocellular carcinomas", CHIN MED J, 113(12), 2000, pp. 1112-1118
94. Pfreundschuh, M
    Exploitation of the B cell repertoire for the identification of human tumor antigens
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    M. Pfreundschuh, "Exploitation of the B cell repertoire for the identification of human tumor antigens", CANC CHEMOT, 46, 2000, pp. S3-S7
95. Knuth, A; Jager, D; Jager, E
    Cancer immunotherapy in clinical oncology
    CANCER CHEMOTHERAPY AND PHARMACOLOGY
    
    A. Knuth et al., "Cancer immunotherapy in clinical oncology", CANC CHEMOT, 46, 2000, pp. S46-S51
96. Jungbluth, AA; Iversen, K; Coplan, K; Kolb, D; Stockert, E; Chen, YT; Old, LJ; Busam, K
    T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues
    PATHOLOGY RESEARCH AND PRACTICE
    
    A.A. Jungbluth et al., "T311 - An anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues", PATH RES PR, 196(4), 2000, pp. 235-242
97. Ishigami, S; Natsugoe, S; Tokuda, K; Nakajo, A; Xiangming, C; Iwashige, H; Aridome, K; Hokita, S; Aikou, T
    Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer
    CANCER LETTERS
    
    S. Ishigami et al., "Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer", CANCER LETT, 159(1), 2000, pp. 103-108
98. Scanlan, MJ; Altorki, NK; Gure, AO; Williamson, B; Jungbluth, A; Chen, YT; Old, LJ
    Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9
    CANCER LETTERS
    
    M.J. Scanlan et al., "Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9", CANCER LETT, 150(2), 2000, pp. 155-164
99. Greiner, J; Ringhoffer, M; Simikopinko, O; Szmaragowska, A; Huebsch, S; Maurer, U; Bergmann, L; Schmitt, M
    Simultaneous expression of different immunogenic antigens in acute myeloidleukemia
    EXPERIMENTAL HEMATOLOGY
    
    J. Greiner et al., "Simultaneous expression of different immunogenic antigens in acute myeloidleukemia", EXP HEMATOL, 28(12), 2000, pp. 1413-1422
100. Shintaku, I; Kawagoe, N; Yutani, S; Hoshi, S; Orikasa, S; Yoshizumi, O; Itoh, K
     Expression of the SART1 tumor rejection antigen in renal cell carcinoma
     UROLOGICAL RESEARCH
     
     I. Shintaku et al., "Expression of the SART1 tumor rejection antigen in renal cell carcinoma", UROL RES, 28(3), 2000, pp. 178-184